Annotation Detail for DNMT3A
Basic Information Top
Gene Symbol: | DNMT3A ( DNMT3A2,M.HsaIIIA ) |
---|---|
Gene Full Name: | DNA (cytosine-5-)-methyltransferase 3 alpha |
Band: | 2p23.3 |
Quick Links | Entrez ID:1788; OMIM: 602769; Uniprot ID:DNM3A_HUMAN; ENSEMBL ID: ENSG00000119772; HGNC ID: 2978 |
Relate to Another Database: | SFARIGene; denovo-db |
Location(AA) | Modification | |
---|---|---|
105 | Phosphoserine. |
Location(AA) | Modifications | Resource |
---|---|---|
102 | Phosphoserine. | Swiss-Prot 53.0 |
Location(AA) | Modification | Resource |
---|---|---|
9 | O-linked | HMM predict |
41 | Phosphothreonine(PKC) | HMM predict |
72 | Phosphoserine(CDC2) | HMM predict |
74 | Phosphoserine(IKK) | HMM predict |
102 | O-linked | HMM predict |
121 | Phosphothreonine(PKC) | HMM predict |
164 | Methylarginine | HMM predict |
193 | Phosphotyrosine(Jak) | HMM predict |
194 | Phosphotyrosine(EGFR) | HMM predict |
233 | Phosphoserine(ATM) | HMM predict |
248 | O-linked | HMM predict |
252 | O-linked | HMM predict |
254 | O-linked | HMM predict |
254 | O-linked | HMM predict |
257 | O-linked | HMM predict |
258 | Phosphothreonine(MAPK) | HMM predict |
258 | O-linked | HMM predict |
258 | O-linked | HMM predict |
258 | Phosphothreonine(CDC2) | HMM predict |
270 | N-linked | HMM predict |
281 | Sulfotyrosine | HMM predict |
281 | Phosphotyrosine(INSR) | HMM predict |
281 | Phosphotyrosine(SRC) | HMM predict |
390 | Phosphoserine(CK2) | HMM predict |
429 | Phosphotyrosine(Syk) | HMM predict |
429 | Phosphotyrosine(SRC) | HMM predict |
433 | Phosphotyrosine(Syk) | HMM predict |
445 | Phosphotyrosine(Abl) | HMM predict |
498 | N-linked | HMM predict |
530 | Phosphotyrosine(Syk) | HMM predict |
537 | S-palmitoyl | HMM predict |
538 | S-palmitoyl | HMM predict |
657 | Phosphotyrosine(Jak) | HMM predict |
688 | Phosphothreonine(PKC) | HMM predict |
- RefSeq ID: NM_022552
- Location:chr2 25309349-25418277
- strand:-
No data |
No data |
Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
---|---|---|---|---|---|---|
CTCF | CD4 | GSE12889 | 25353664 | 25353854 | 190 | 0 |
CTCF | CD4 | SISSRdata | 25353664 | 25353854 | 190 | 0 |
CTCF | G2 | GSE9613 | 25333523 | 25333757 | 234 | 0 |
CTCF | G2 | GSE9613 | 25351450 | 25351638 | 188 | 0 |
CTCF | G2 | GSE9613 | 25353319 | 25353734 | 415 | 0 |
ER | MCF7 | GSE19013 | 25354330 | 25354804 | 474 | 0 |
NFkBII | GM12878 | GSE19485 | 25349505 | 25352419 | 2914 | 0 |
Oct1 | H2O2-Hela | GSE14283 | 25335322 | 25335363 | 41 | 0 |
Oct1 | H2O2-Hela | GSE14283 | 25347997 | 25348023 | 26 | 0 |
Oct1 | H2O2-Hela | GSE14283 | 25357131 | 25357157 | 26 | 0 |
Oct1 | Hela | GSE14283 | 25335324 | 25335369 | 45 | 0 |
USF1 | HepG2 | E | 25329159 | 25330120 | 961 | 0 |
USF1 | HepG2 | E | 25330577 | 25331336 | 759 | 0 |
USF1 | HepG2 | E | 25331826 | 25332794 | 968 | 0 |
p63 | keratinocytes | GSE17611 | 25355032 | 25356069 | 1037 | 0 |
Micro RNA Name | Stem Loop Name | The chromosome that miRNA located | Publication |
---|---|---|---|
hsa-let-7f | hsa-let-7f-1 | 9 | 21136442 |
hsa-let-7f | hsa-let-7f-2 | X | 21136442 |
hsa-miR-143 | hsa-mir-143 | 5 | 19638978 |
hsa-miR-143* | hsa-mir-143 | 5 | 19638978 |
hsa-miR-16 | hsa-mir-16-1 | 13 | 20643754 |
hsa-miR-16 | hsa-mir-16-2 | 3 | 20643754 |
hsa-miR-17 | hsa-mir-17 | 13 | 20643754 |
hsa-miR-17* | hsa-mir-17 | 13 | 20643754 |
hsa-miR-29a | hsa-mir-29a | 7 | 21081840 |
hsa-miR-29a | hsa-mir-29a | 7 | 20643754 |
hsa-miR-29a | hsa-mir-29a | 7 | 20478395 |
hsa-miR-29a | hsa-mir-29a | 7 | 17890317 |
hsa-miR-29a* | hsa-mir-29a | 7 | 21081840 |
hsa-miR-29a* | hsa-mir-29a | 7 | 20643754 |
hsa-miR-29a* | hsa-mir-29a | 7 | 20478395 |
hsa-miR-29a* | hsa-mir-29a | 7 | 17890317 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 21081840 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 21081840 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 20643754 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 20643754 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 19509302 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 19509302 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 19211935 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 19211935 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 20478395 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 20478395 |
hsa-miR-29b | hsa-mir-29b-1 | 7 | 17890317 |
hsa-miR-29b | hsa-mir-29b-2 | 1 | 17890317 |
hsa-miR-29b-1* | hsa-mir-29b-1 | 7 | 21081840 |
hsa-miR-29b-1* | hsa-mir-29b-1 | 7 | 20643754 |
hsa-miR-29b-1* | hsa-mir-29b-1 | 7 | 19211935 |
hsa-miR-29b-1* | hsa-mir-29b-1 | 7 | 20478395 |
hsa-miR-29b-1* | hsa-mir-29b-1 | 7 | 17890317 |
hsa-miR-29b-2* | hsa-mir-29b-2 | 1 | 21081840 |
hsa-miR-29b-2* | hsa-mir-29b-2 | 1 | 20643754 |
hsa-miR-29b-2* | hsa-mir-29b-2 | 1 | 20478395 |
hsa-miR-29b-2* | hsa-mir-29b-2 | 1 | 17890317 |
hsa-miR-29c | hsa-mir-29c | 1 | 21136442 |
hsa-miR-29c | hsa-mir-29c | 1 | 21081840 |
hsa-miR-29c | hsa-mir-29c | 1 | 20643754 |
hsa-miR-29c | hsa-mir-29c | 1 | 20478395 |
hsa-miR-29c | hsa-mir-29c | 1 | 17890317 |
hsa-miR-29c* | hsa-mir-29c | 1 | 21136442 |
hsa-miR-29c* | hsa-mir-29c | 1 | 21081840 |
hsa-miR-29c* | hsa-mir-29c | 1 | 20643754 |
hsa-miR-29c* | hsa-mir-29c | 1 | 20478395 |
hsa-miR-29c* | hsa-mir-29c | 1 | 17890317 |
hsa-miR-369-5p | hsa-mir-369 | 14 | 21136442 |
hsa-miR-371-3p | hsa-mir-371 | 19 | 21136442 |
hsa-miR-371-5p | hsa-mir-371 | 19 | 21136442 |
hsa-miR-499-3p | hsa-mir-499 | 20 | 21136442 |
hsa-miR-499-5p | hsa-mir-499 | 20 | 21136442 |
ID in Tarbase | Data Type | Support Type | miRNA | Gene | Direct Support | Publication |
---|---|---|---|---|---|---|
582 | mRNA cleavage | TRUE | miR-29a | DNMT3A | Luciferase assay - mutant MRE | 17890317 |
586 | mRNA cleavage | TRUE | miR-29b | DNMT3A | Luciferase assay - scrambled miRNA | 17890317 |
589 | mRNA cleavage | TRUE | miR-29c | DNMT3A | Luciferase assay - scrambled miRNA | 17890317 |
Ensembl | Protein Type | Differentially expressed in | Pathology or Event | Mis Regulation | Gene Expression | Tumour Involvement |
ENSG00000119772 | "neuronal and glial cells, G1-to-S transition" | G1 cell cycle arrest | up regulated | "lymphocyte, muscle cell" | "benign tumour, malignant tumour, carcinoma, leukaemia, sarcoma" | |
ENSG00000119772 | G1/S phase transition | Non-small-cell lung cancer (NSCLC) | down regulated | "lymphocyte, muscle cell" | "benign tumour, malignant tumour, carcinoma, leukaemia, sarcoma" | |
ENSG00000119772 | nasopharyngeal epithelium | Non-small-cell lung cancer (NSCLC) | down regulated | "lymphocyte, muscle cell" | "benign tumour, malignant tumour, carcinoma, leukaemia, sarcoma" |